Cellular accumulation and retention of the technetium-99m-labelled hypoxia markers BRU59–21 and butylene amine oxime

Nuclear Medicine and Biology

Volumn 28, Issue 8, 2001, Pages 949-957

  Zhang, Xiuguo ^a   Melo, Tricia ^a   Rauth, A M ^a   Ballinger, James R ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

BRU59 21; Butylene amine oxime; Hypoxia; Technetium 99m

Indexed keywords

BMS 194796; BRU 5921; BUTYLENE AMINE OXIME; CYTOCHROME P450 REDUCTASE; OXIME DERIVATIVE; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; OXO[3,3,9,9 TETRAMETHYL 5 OXA 6 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

AIR; ANIMAL CELL; ARTICLE; CELL HYPOXIA; CHO CELL; CONTROLLED STUDY; DISEASE MARKER; DRUG ACCUMULATION; DRUG RETENTION; DRUG SCREENING; ELECTRON; HYPOXIC CELL; IMAGING; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANOXIA; CHO CELLS; CRICETINAE; IMIDAZOLES; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 0035164960     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00267-0     Document Type: Article

References (29)

1. Technetium labelled agents for imaging tissue hypoxia in vivo
2. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia
3. Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster overy cells overexpressing DT-diaphorase
4. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome C (P-450) reductase
5. 5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells
6. Towards new transition metal-based hypoxic selective agents for therapy and imaging
7. 3H]fluoromisonidazole
8. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
9. Technetium-99m-labeled HL91 to identify tumor hypoxia: Correlation with fluorine-18-FDG
10. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors
11. 2 predicts survival in advanced cancer of the uterine cervix
12. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue
13. 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model
14. TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: Synthesis, characterization, and xanthine oxidase-catalyzed reduction
15. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (Iodoazomycin arabinoside: IAZA): A novel marker of tissue hypoxia
16. Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxia
17. BRU59-21, a second-generation technetium-99m-labeled 2-nitroimidazole for imaging hypoxia in tumors
18. Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics
19. 18F]fluoromisonidazole: A pretherapy study of 37 patients
20. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro
21. Genetic instability induced by the tumor microenvironment
22. 4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer
23. Technetium-99m HL91 uptake as a tumour hypoxia marker: Relationship to tumour blood flow
24. Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells
25. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside
26. An experimental and analytical study of oxygen depletion in stirred cell suspensions
27. 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia
28. 99mTc-BnAO (HL-91): A non-nitroaromatic compound for hypoxic cell detection